Boston Partners
VMD icon

Boston Partners’s Viemed Healthcare VMD Stock Holding History

Boston Partners’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-38,396
Closed -$261K – 812
2025
Q3 		$261K Sell
38,396
-5,749
-13% -$38.9K ﹤0.01% 729
2025
Q2 		$305K Buy
44,145
+67
+0.2% +$455 ﹤0.01% 686
2025
Q1 		$321K Buy
44,078
+328
+0.7% +$2.58K ﹤0.01% 667
2024
Q4 		$351K Sell
43,750
-35,203
-45% -$305K ﹤0.01% 673
2024
Q3 		$579K Buy
78,953
+1,196
+2% +$8.54K ﹤0.01% 665
2024
Q2 		$509K Buy
77,757
+46,282
+147% +$349K ﹤0.01% 658
2024
Q1 		$297K Hold
31,475
– – ﹤0.01% 740
2023
Q4 		$247K Sell
31,475
-24,955
-44% -$181K ﹤0.01% 675
2023
Q3 		$380K Buy
56,430
+13,468
+31% +$110K ﹤0.01% 670
2023
Q2 		$420K Sell
42,962
-5,770
-12% -$58.6K ﹤0.01% 643
2023
Q1 		$471K Hold
48,732
– – ﹤0.01% 603
2022
Q4 		$368K Buy
+48,732
New +$330K ﹤0.01% 630

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Boston Partners's VMD Position: Q4 2025 in Review

Boston Partners sold out of Viemed Healthcare (VMD) in Q4 2025, closing a stake of 38,396 shares — an estimated $261K sold.

Boston Partners first reported a position in VMD in Q4 2022 and held it in 12 quarters. The position peaked at $579K in Q3 2024. 132 funds tracked by Wall St. Rank hold VMD as of Q4 2025.

  • Boston Partners reported no remaining Viemed Healthcare position as of Q4 2025 after selling out during the quarter.
  • Boston Partners sold 38,396 Viemed Healthcare shares in Q4 2025, an estimated $261K.
  • Boston Partners first reported a position in Viemed Healthcare in Q4 2022 and held it in 12 quarters.
  • Boston Partners's Viemed Healthcare position peaked at $579K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Viemed Healthcare as of Q4 2025.

Based on Boston Partners's 13F filing for Q4 2025, filed 13 Feb 2026.